Chiron Buys Firm to Develop Prion Test
- Share via
Chiron Corp., the No. 2 maker of flu vaccines, said Tuesday that it bought closely held Prion Solutions Inc. as it worked to develop a test that could be used to screen blood donations for a protein linked to mad cow disease.
Terms weren’t disclosed.
Prion Solutions, based in La Jolla, focuses on research into variant Creutzfeldt-Jakob disease and other diseases related to the prion, a protein particle.
Emeryville, Calif.-based Chiron said technology developed by Prion Solutions complemented its research to screen blood donations for variant Creutzfeldt-Jakob disease.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
